Evidence map›Paper›PMID 31785547›Full record

ArticleThe International journal on drug policy2020

A qualitative study of e-cigarette emergence and the potential for renormalisation of smoking in UK youth.

R Brown, L Bauld, E de Lacy, B Hallingberg, O Maynard, J McKell, L Moore, G Moore

Abstract read
In one paragraph

Article in The International journal on drug policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Zebrafish (International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Electronic cigarette devices targeting youth in Korea.Tobacco prevention & cessation · 2022
    Article
  15. Review
  16. Article
  17. Use of E-Cigarettes and Associated Factors among Youth in Thailand.Asian Pacific journal of cancer prevention : APJCP · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

R BrownCentre for the Development and Evaluation of Complex Interventions for Public Health Improvement, Cardiff University, UK. Electronic address: brownr14@cardiff.ac.uk.
L BauldUsher Institute of Population Health Sciences & Informatics, University of Edinburgh, UK; Director, SPECTRUM Consortium.
E de LacyCentre for the Development and Evaluation of Complex Interventions for Public Health Improvement, Cardiff University, UK.
B HallingbergDepartment of Applied Psychology, Cardiff Metropolitan University.
O MaynardMRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, UK/UK Centre for Tobacco and Alcohol Studies (UKCTAS) and School of Psychological Science, University of Bristol, Bristol, UK.
J McKellInstitute for Social Marketing, University of Stirling and UK Centre for Tobacco and Alcohol Studies, UK.
L MooreMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, UK.
G MooreCentre for the Development and Evaluation of Complex Interventions for Public Health Improvement, Cardiff University, UK; SPECTRUM Consortium.

Funding

British Heart FoundationCancer Research UKChief Scientist Office SPHSU14Department of Health 16/57/01Department of Health PHR/16/57/01Medical Research Council MC_UU_12017/14Medical Research Council MR/K023233/1Medical Research Council MR/KO232331/1Wellcome Trust
6 · The paper itself

Abstract

backgroundGrowth of e-cigarette use among smokers has raised concerns over uptake by non-smokers, particularly young people. Legislative changes aimed in part at reducing youth exposure to e-cigarettes include the EU Tobacco Products Directive (TPD). A core justification for such measures is the belief that e-cigarettes can lead to tobacco smoking through mechanisms of renormalisation including: mimicking and normalizing the act of smoking; increasing product acceptability via marketing; nicotine exposure. These mechanisms are here explored in relation to findings from qualitative research.

methodsThis paper reports results from twenty-one group interviews with 14-15 year olds in Wales, England and Scotland, conducted as part of an ongoing evaluation of the impact of the TPD on youth smoking and e-cigarette use. Interviews were conducted around the end of the transitional period for TPD implementation, and explored perceptions of e-cigarettes and tobacco, as well as similarities and differences between them.

resultsYoung people differentiated between tobacco and e-cigarettes, rejecting the term e-cigarette in favour of alternatives such as 'vapes'. Experimental or occasional use was common and generally approved of where occurring within social activity with peers. However, regular use outside of this context was widely disapproved of, unless for the purpose of stopping smoking. Increased prevalence of e-cigarettes did not challenge strongly negative views of smoking or reduce perceived harms caused by it, with disapproval of smoking remaining high. Nicotine use was variable, with flavour a stronger driver for choice of e-liquid, and interest more generally.

conclusionThe extent to which participants differentiated between vaping and smoking, including styles and reasons for use in adults and young people; absence of marketing awareness; and continued strong disapproval of smoking provides limited support for some of the potential mechanisms through which e-cigarettes may renormalise smoking. However caution over nicotine exposure is still necessary.

Indexed as

AdolescentElectronic Nicotine Delivery SystemsEnglandFemaleHumansInterviews as TopicMaleQualitative ResearchScotlandTobacco SmokingVapingWalesE-cigaretteRenormalisationTobaccoYouth

Identifiers

PMID31785547
PMCPMC6983925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.